AGP Executive Report
Last update: 9 hours agoPharma: Teva won U.S. FDA approval for Weltruza, a once-monthly schizophrenia injection, and expects to launch it in the coming weeks. Financial Compliance: Israeli investigators are probing alleged tax evasion tied to cryptocurrency trading worth tens of millions of dollars; a suspect was detained and assets seized. Health-Tech Funding: Tel Aviv-based Phantom GI raised $5 million to develop a needle-based alternative to major bowel surgery, with early U.S. clinical studies planned. Fintech: Capitolis raised $200 million at a $1.9 billion valuation. Renewable Energy: Enlight Renewable Energy acquired a ready-to-build 100-megawatt battery-storage project in Finland, extending its international expansion.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.